FDA Registration
Active
🇺🇸 United States
R-Biopharm Clinical USA Inc.
Reg #: 3016548670
·
FEI: 3016548670
·
Expires 2026
Products
5
Proprietary Names
3
Establishment Types
1
Classifications
5
Registration Details
- Registration Name
- R-Biopharm Clinical USA Inc.
- Registration Number
- 3016548670
- FEI Number
- 3016548670
- Status
- Active
- Expiry Year
- 2026
- Initial Importer
- Yes
- Address
- 870 Vossbrink Dr
- City
- Washington
- State
- MO
- ZIP
- 63090
- Country
- US
Regulatory Submissions
- 510(k) Number
- K171511
Owner / Operator
- Firm Name
- R-Biopharm Clinical USA Inc.
- Operator Number
- 10088745
- Address
- 870 Vossbrink Drive
- City
- Washington
- State
- MO
- Postal Code
- 63090
- Country
- US
Products
| Device Name | Product Code | Device Class | Medical Specialty | Exempt | Created |
|---|---|---|---|---|---|
| Reagents For Detection Of Norovirus Nucleic Acid | PIQ | Class 2 | Microbiology | No | 2023-10-19 |
| Real Time Nucleic Acid Amplification System | OOI | Class 2 | Clinical Chemistry | No | 2023-10-19 |
| Norovirus Serological Reagent | OUC | Class 2 | Microbiology | No | 2023-10-19 |
| Protein, Complement, Antigen, Antiserum, Control | DHL | Class 1 | Immunology | No | 2023-11-28 |
| P-Toluenesulphonyl-L-Arginine Methyl Ester (U.V.), Trypsin | JNN | Class 1 | Clinical Chemistry | No | 2026-03-26 |
Proprietary Names
RIDA®GENE Norovirus GI/GII
RIDA® CCD-Inhibitor
RIDASCREEN® Pancreatic Elastase ELISA
Establishment Types
Complaint File Establishment per 21 CFR 820.198